Tara Gomes


Canada Research Chair in Drug Policy Research and Evaluation

Tier 2 - 2019-02-01
University of Toronto
Canadian Institutes of Health Research

416-864-6060, ext. 77046
gomesT@smh.ca

A Prescription for Evidence-Informed Public Health Care


Prescription drugs cost more than $34 billion each year in Canada. Dr. Tara Gomes, Canada Research Chair in Drug Policy Research and Evaluation, is trying to ensure that we are spending this money wisely.

She is leading an innovative research program on best practices for safe, effective and affordable prescription drug policies. Her resolve to connect patients, doctors, pharmacists and policy-makers through her work is influencing publicly funded drug programs around the world.

Reconciling increasing drug costs and expanded drug coverage with our need for safe, affordable medicine is at the heart of Gomes’ research. By applying collaborative, population-based methods, she and her research team are strengthening drug policy decision-making through evidence, user-friendly tools and best practices.

For example, her approach to making better, timelier use of large health databases has improved the integration of evidence into decision-making about what medicines get covered, how they are prescribed, and whether new drug policies achieve their intended goals. This approach has been critical in monitoring patterns of opioid use in Canada and improving related guidelines and policies. Her analyses of the drivers of high-cost drug beneficiaries, and the impacts of changing public drug funding in Ontario, will help ensure programs are safe and sustainable in the long-term.

Ultimately, Gomes’ work strives to integrate research with real life by providing evidence-based solutions that will improve lives as well as the public systems we depend on.